PRESS RELEASE published on 03/28/2023 at 11:02, 3 years 2 months ago Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership
PRESS RELEASE published on 03/28/2023 at 11:01, 3 years 2 months ago EQS-Adhoc: Evotec and Bristol Myers Squibb expand strategic neurodegeneration partnership
PRESS RELEASE published on 03/28/2023 at 07:00, 3 years 2 months ago Evotec SE preliminary fiscal year 2022 results: 'Ahead of the curve' – very strong performance in a challenging year
PRESS RELEASE published on 03/24/2023 at 07:30, 3 years 3 months ago Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis
PRESS RELEASE published on 03/21/2023 at 11:50, 3 years 3 months ago Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023
PRESS RELEASE published on 03/16/2023 at 07:30, 3 years 3 months ago Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb
PRESS RELEASE published on 02/10/2023 at 07:30, 3 years 4 months ago Evotec receives € 150 m loan from European Investment Bank
PRESS RELEASE published on 02/09/2023 at 07:30, 3 years 4 months ago Evotec and Related Sciences expand integrated drug discovery and development partnership
PRESS RELEASE published on 02/07/2023 at 07:30, 3 years 4 months ago Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
PRESS RELEASE published on 01/26/2023 at 07:30, 3 years 5 months ago Evotec announces agreement with Janssen to develop immune-based therapies
Published on 06/27/2026 at 01:40, 9 hours 26 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 11 hours 6 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 12 hours 6 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 12 hours 16 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 12 hours 51 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 11 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 11 hours 1 minute ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 11 hours 30 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 11 hours 30 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 11 hours 38 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 17 hours 21 minutes ago Descriptif du programme de rachat d'actions
